Fulltext

Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries

Ammerlaan, Heidi ; Seifert, Harald ; Harbarth, Stephan ; Brun-Buisson, Christian ; Torres, Antoni ; Antonelli, Massimo ; Kluytmans, Jan ; Bonten, Marc

In: Clinical Infectious Diseases, 2009, vol. 49, no. 7, p. 997-1005

Aggiungi alla tua lista
    Titre
    • Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries
    Auteur
    • Ammerlaan, Heidi. Department of Medical Microbiology, Amsterdam, the Netherlands
    • Seifert, Harald. Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany
    • Harbarth, Stephan. Infection Control Program, Geneva University Hospitals and Medical School, Geneva, Switzerland
    • Brun-Buisson, Christian. Medical Intensive Care Unit, University of Paris, Hospital Henri Mondor, Paris, France
    • Torres, Antoni. Cap de Servei de Pneumologia i Allérgia Respiratória, Institut Clìnic del Tórax, Hospital Clìnic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunver, Ciber de Enfermedades Respiratorias, University of Barcelona, Barcelona, Spain
    • Antonelli, Massimo. Department of Intensive Care and Anesthesiology, Universitá Cattolica del Sacro Cuore, Rome, Italy
    • Kluytmans, Jan. Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, Amsterdam, the Netherlands
    • Bonten, Marc. Department of Medical Microbiology, Amsterdam, the Netherlands
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • Clinical Infectious Diseases, 2009, vol. 49, no. 7, p. 997-1005. The University of Chicago Press
    Autre version électronique
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:299247
    Summary
    Background.Little is known about the incidence of inadequate treatment of severe Staphylococcus aureus infection in Europe. We aimed to evaluate the adequacy of antibiotic therapy for S. aureus bacteremia (SAB), to identify determinants of inadequate treatment, and to determine the effect of inadequate treatment on patient outcome in a representative selection of hospitals in 9 Western European countries. Methods.In this retrospective cohort study, all adult patients with SAB (due to methicillin-susceptible S. aureus [MSSA] or methicillin-resistant S. aureus [MRSA]) who were admitted to 60 randomly selected hospitals from 1 November 2007 through 31 December 2007 were included. Adequate antimicrobial therapy was defined as intravenous administration of at least 1 antibiotic to which the isolate showed in vitro susceptibility that was initiated within 2 days after onset of SAB. Results.A total of 334 SAB episodes (257 due to MSSA and 77 due to MRSA) were included. Ninety-four patients (28%) received inadequate empirical therapy (21% in the MSSA group and 52% in the MRSA group). Both length of stay before SAB onset and methicillin-resistant infection were associated with inadequate therapy, with adjusted odds ratios (ORs) of 1.01 (95% confidence interval [CI], 1.00-1.03) and 3.7 (95% CI, 2.2-6.4), respectively. Age (OR, 1.06; 95% CI, 1.03-1.10), Charlson comorbidity score (OR, 2.1; 95% CI, 1.2-3.6), severe sepsis or septic shock (OR, 2.7; 95% CI, 1.5-4.8), and intensive care unit stay at onset of SAB (OR, 2.9; 95% CI, 1.5-5.6) but not inadequate treatment (OR, 0.7; 95% CI, 0.4-1.3) were associated with increased 30-day mortality. Conclusion.Inadequate empirical antimicrobial therapy for SAB is common in Western Europe and is strongly associated with infection caused by MRSA. In this study, inadequate treatment was not associated with increased 30-day mortality rates